Contact Us
US: +1 512 898-9222
SG: +65 3138-4148
EMAIL: Japan@asiaactual.com
Medical device labeling requirements in Japan are specified by the Pharmaceuticals and Medical Devices Agency (PMDA), in Artcle 52 of the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices.
In Japan, local labeling is listed on package inserts, ‘tempu bunsho’. The package inserts should contain the information presented in the Instructions for Use (IFU) in Japanese. The Market Authorization Holder (MAH) or Manufacturer of Pharmaceuticals must affix packaging inserts as a Clearance Release Judgement requirement. Packaging inserts can be affixed in the factory of origin or done in Japan by the warehousing manufacturer. Notification is required before the medical device or IVD device can be marketed in Japan (or at the time of new approval) and when revising the package insert.
Pharmacy/Ethical drugs (not including IVD, pharmacy-compounded drugs or over-the-counter drugs), Class IV medical devices and all regenerative medical products are subject to the package insert notification system. Exemptions to be specified through ordinances of the Ministry of Health, Labor and Welfare (MHLW).
Package inserts must include:
Standards for package inserts for IVD devices are specified in Article 41-3.
IVDs are exempt from packaging requirements given:
For pharmaceutical products listed in the Japanese Pharmacopoeia (JP), information specific in the JP must be included in the package insert. Marketing designated for pharmaceuticals must be immediately published using the electronic data processing system or other information-communication technologies.
Contact Asia Actual to see if our Japan labeling solutions are right for your needs.
US: +1 512 898-9222
SG: +65 3138-4148
EMAIL: Japan@asiaactual.com
実際の亞洲
เอเชีย แอคชวล
एशिया वास्तविक
실제 아시아
515 Congress Avenue, Suite 2100
Austin, TX 78701
+1 512 898-9222
Contact Us
Privacy Policy
116 Changi Road, #04-05